FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Allied Corp. Stock AnalysisComprehensive stock analysis for Allied Corp. (ALID) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisALID
ALID
Allied Corp.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
ALID
Home🔹Stocks🔹Allied Corp.

Allied Corp.

🇺🇸ALID•OTC

Allied Corp.

🇺🇸ALID•OTC
Market cap
$57.75K
Sentiment

Your view on ALID

Mkt Cap
$57.75K
Sentiment
Your view
ALID
Allied Corp.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
ALID
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Allied Corp.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Paul Bullock
Headquarters
1405 St. Paul Street, Kelowna, BC, CA
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Paul Bullock
Headquarters
1405 St. Paul Street, Kelowna, BC, CA
Description

Allied Corp., a medical cannabis production company, engages in the research, development, and production of cannabinoid health solutions in the United States.

It offers hemp-derived natural health products, including Liberty, a hemp-derived cannabidiol (CBD) tincture; Tactical Hydration, a CBD infused electrolyte replacement drink; FIZZ Tablets for adding in a water bottle; Battle Balm, a CBD roll on activity rub for aches and pains; and Quick Hit, a CBD gummy under the Tactical Relief brand.

The company also provides Hydrosport CBD Drink, a CBD infused electrolyte replacement drink with sodium citrate electrolyte replacement; Hydrosport Tincture, a CBD tincture fortified with specific terpene profile; FIZZ Tablets for adding to a water bottle; Sport Rub, a CBD post-activity rub for aches and pains; and Quick Hit, a CBD gummy with vitamin B12 under the Equilibrium Bio brand.

In addition, it offers Skin Structure, a facial formula topically applied to enhance skin's radiance and youthfulness; Eye Recover that helps the eye skin ward off free radicals, as well as helping to protect against sun damage; Glossy Lip Recover, which moisturizes and nourishes lips; Skin Designer that stimulates cell regeneration while minimizing age spots; Vitamin Absolute, a moisturizing facial oil; and Absolute Recover, a formulation that allows the infused bioactive compounds to be delivered directly to the desired areas of inflammation, pain, and other skin ailments under the MaXXa brand.

In addition, it is developing ALID 10 and ALID 11, a pharma product, which is in Phase I clinical trial for treating post-traumatic stress disorder. The company was incorporated in 2013 and is headquartered in Kelowna, Canada.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Allied Corp., and the rating behind it. ALID last traded at $0.0005; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Allied Corp.. Starting points for Allied Corp.: EPS -$0.11, beta -0.79 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Allied Corp.. Allied Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Allied Corp.. Trailing twelve-month EPS for Allied Corp. stands at -$0.11. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Allied Corp.. Allied Corp. has reported as a listed company since 2019. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Allied Corp. valued side by side against its closest peers. Allied Corp. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Allied Corp., and how their positions are changing. At a $57,748 market value, institutional positions materially move Allied Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Allied Corp. executives and directors. Shares of Allied Corp. have traded between $0.0005 and $0.04 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Allied Corp.. Allied Corp. is a $57,748 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Allied Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Allied Corp.. Coverage tracks Allied Corp. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • BMMJ — Body and Mind Inc.
  • CBDY — Target Group Inc.
  • CNNA — Cann American Corp.
  • CPMD — CannaPharmaRX, Inc.
  • EXMT — Anything Technologies Media, Inc.
  • MJNA — Medical Marijuana, Inc.
  • MSTH — Mystic Holdings, Inc.

More Drug Manufacturers - Specialty & Generic companies

  • HASH.V — Simply Solventless Concentrates
  • HBRM — Herborium Group, Inc.
  • HCANF — Halo Collective Inc.
  • HCM — HUTCHMED (China) Limited
  • HDRPF — Epsilon Healthcare Limited
  • HEMP — Hemp, Inc
  • HENC — Hero Technologies Inc.
  • HKMPF — Hikma Pharmaceuticals PLC
  • HKMPY — Hikma Pharmaceuticals PLC
  • HLBBF — H. Lundbeck A/S
  • HLN — Haleon plc
  • HLNCF — Haleon plc

News

Latest Market News